Driving Antibody Optimization Using a Mix of Sequence, Structure, Computation, and Screening

Time: 11:15 am
day: Day Two


  • Addressing multi-goal lead optimization: Developability, immunogenicity, affinity, specificity
  • When do you design from sequence, model structure, search computationally, and/or screen libraries?
  • Discussing ATRC-101 and ATRC-301 clinical candidate optimization case studies